Trouble Under The Rally’s Surface? Plus Improvements in Office Demand 8/8/24
CNBC's "Fast Money"
00:00
Eli Lilly's Strategic Growth in Pharma
This chapter examines Eli Lilly's recent success in the pharmaceutical sector, particularly due to its GLP1 weight loss drugs and impressive Q2 results. It highlights the company's expansion plans, including new facilities and international market entry, as well as the competitive landscape for upcoming drug launches. Additionally, the discussion touches on stock performance and the outlook for potential revenue growth from innovative products amid an evolving market.
Play episode from 11:21
Transcript
